Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study
Y. Gao (zhengzhou, China), M. Lonergan (Dundee, United Kingdom), H. Abo-Leyah (Dundee, United Kingdom), S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milan, Italy), P. Regis-Burgel (Paris, France), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), E. Polverino (Barcelona, Spain), S. Skrgat (Golnik, Slovenia), M. Van Der Eerden (Rotterdam, Netherlands), W. Boersma (Alkmaar, Netherlands), O. Sibila (Barcelona, Spain), M. Mcdonnell (Galway, Ireland), P. Kauppi (Helsinki, Finland), V. Botnaru (Chisinau, Republic of Moldova), E. Van Braeckel (Ghent, Belgium), N. Lorent (Leuven, Belgium), J. Rademacher (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), M. R Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), J. Stuart Elborn (Belfast, United Kingdom), M. L Crichton (Dundee, United Kingdom), P. C Goeminne (Sint Niklaas, Belgium), M. Shteinberg (Haifa, Israel), A. Shoemark (Dundee, United Kingdom), J. Altenburg (Amsterdam, Netherlands), J. D Chalmers (Dundee, United Kingdom)
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Gao (zhengzhou, China), M. Lonergan (Dundee, United Kingdom), H. Abo-Leyah (Dundee, United Kingdom), S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milan, Italy), P. Regis-Burgel (Paris, France), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), E. Polverino (Barcelona, Spain), S. Skrgat (Golnik, Slovenia), M. Van Der Eerden (Rotterdam, Netherlands), W. Boersma (Alkmaar, Netherlands), O. Sibila (Barcelona, Spain), M. Mcdonnell (Galway, Ireland), P. Kauppi (Helsinki, Finland), V. Botnaru (Chisinau, Republic of Moldova), E. Van Braeckel (Ghent, Belgium), N. Lorent (Leuven, Belgium), J. Rademacher (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), M. R Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), J. Stuart Elborn (Belfast, United Kingdom), M. L Crichton (Dundee, United Kingdom), P. C Goeminne (Sint Niklaas, Belgium), M. Shteinberg (Haifa, Israel), A. Shoemark (Dundee, United Kingdom), J. Altenburg (Amsterdam, Netherlands), J. D Chalmers (Dundee, United Kingdom). Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study. 3336
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: